Cardiomatics Seed

Select partners: Tessinum, Augustinum, doctoRees, Herz- und Gefäßpraxis am Druidenstein, Internistisch / Hausärztliche Gemeinschaftspraxis, PZU Zdrowie.
Primary contact
Wojciecha Weissa 7
31-339 Krakow
Poland
+48 790 261 534
Wojciecha Weissa 7
31-339 Krakow
Poland
+48 790 261 534
Funding 💰
Total €4.4M
Last round 🔗 €2.7
August 20, 2021.
August 20, 2021.
Select investors Kaya, Poland’s National Center for Research & Development, Nina Capital, Nova Capital, Innovation Nest
Key people 🧑🤝🧑
- Rafał Samborski - CEO
- Mariusz Mąsior - CTO
- Katarzyna Barczewska - Head of R&D
- Przemyslaw Tadla - Head of Partnerships
- Krzysztof Homa - Business Development
Highlights ⭐
- Pan-European reach: Cardiomatics' software is being used by more than 700 customers in 10+ countries, including Switzerland, Denmark, Germany and Poland.
- Rock-solid tech: The company's algorithms have been trained from more than 10 billion heartbeats from approximately 100,000 patients and is systematically growing.
- EU's first approved AI medical device: Cardiomatics was the first AI-based solution approved as a medical device in Europe.
- Expansion plans: The company aims to further expand across Europe and eventually obtain FDA certification and enter the US market.
Video ▶️
Awards & Recognitions 🏆
- 2021 WorldFestival Top 50 Startup Award Winners 🔗
Quotes 💬
“
In the field of cardiac electrophysiology, Cardiomatics facilitates and speeds up the diagnosis of arrhythmia.
— Paweł Balsam, BA, MD, PhD, FESC
“
It used to be very time-consuming to analyze long-term recordings with our conventional Holter software. Using Cardiomatics, the interpretation is now fast and reliable.
— Dr. med. Ulrich Ingold, Kardiologie Interlaken-Unterseen, Switzerland
“
The web-based platform is very simple and user-friendly. After uploading the raw signal of the ECG, we get access to a detailed report within a few hours. In a clinical routine, this can save a lot of time compared to the time-consuming analysis of Holter recordings with conventional Holter software.
— Prof. Michael Kühne, MD, Head of Clinic Atrial Fibrillation, University Hospital Basel, Switzerland
Last update: August 16, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more